Your search history is turned on.
Date: April 18, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Material Change Report - Form 51-102F3 - April 18 2024 FORM 51 102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company BioMark Diagnostics Inc. (the Issuer) 130 3851 Shell Rd Richmond, BC V6X 2W2 Item 2: Date of Material Change April 18, 2024 Item 3: News Release A news release was issued and disseminated on April 18, 2024, ...
BioMark Announces Warrant Extension and Granting of Options Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, is pleased to announce that the Company intends to amend the terms of 5,062,000 the non-br...
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioMark to Advance Development of Cancer Treatment for Glioblastoma The Company secured collaborative research funding from Research Manitoba and Mitacs for an animal proof-of-concept study. Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company with a focu...
Date: February 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Guoyu Huang, Interim Chief Financial Officer of BioMark Diagnostics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of BioMark Diagnostics Inc. (the issuer) for the interim perio...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Rashid Ahmed Maula Bux, Chief Executive Officer of BioMark Diagnostics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of BioMark Diagnostics Inc. (the issuer) for the interi...
_ 1 BIOMARK DIAGNOSTICS INC. Form 51-102F1 Managements Discussion & Analysis Quarterly Report For the Quarter Ended December 31, 2023 About This Managements Discussion & Analysis All references in this managements discussion and analysis, or MD&A, to the Company, BioMark, we, us or our refer to BioMark Dia...
Biomark Diagnostics Inc. Condensed Consolidated Interim Financial Statements For the nine-month period ended December 31, 2023 and 2022 (Stated in Canadian Dollars) (Unaudited - Prepared by Management) NOTICE OF NO AUDITOR REVIEW OF CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS Under National Instrument 51-102, if an auditor has not performed ...
Date: February 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, and Rubix LS, a culturally competent patient medi...
Date: February 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Theresa Peterson Joins Biomark's Advisory Team Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced-stage liquid biopsy company with a focus on hard-to-detect and treat cancers is pleased to announce that Mrs. Theresa Peterson as a new member of BioMark's Advisory team. Mr. Rashid Ahmed Bux, ...
Date: January 8, 2024 Jurisdictions: British Columbia, Quebec
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...